User Experience Performance Global Diagnostic Results

Webpage: https://investor.tmanpharmaceutical.com

Device: Desktop Computer

Region: Global (total 6 regions)

T.Man Pharmaceutical's Global Website Performance: 48% Score in Europe Impacts Healthcare Access

Critical performance issues detected across T.Man Pharmaceutical's investor portal, with European scores 11% below global standards. Poor loading times affect pharmaceutical product visibility and investor relations in key markets.

Analyze Your Site Performance on PulseDX

Average Score

53
Average Page Performance Needs Improvement
Click on the country to view detailed metrics for each region
Ireland (Dublin)
48 / 100
Poor Performance
Germany (Frankfurt)
54 / 100
Performance Needs Improvement
United States East (Virginia)
54 / 100
Performance Needs Improvement
Australia (Sydney)
56 / 100
Performance Needs Improvement
United States West (Oregon)
57 / 100
Performance Needs Improvement
Japan (Tokyo)
Website Refused Access or No Response

Healthcare Access at Risk: T.Man's 53% Global Score Needs Immediate Attention

Your pharmaceutical platform shows concerning performance gaps across 5 major regions, with European markets scoring lowest at 48%. Website speed issues may be limiting access to vital healthcare information.

Start Your Free Website Analysis Now